// App-Quantinova.ai

TCT-441 : Optical Coherence Tomography assessment of the implantation of Everolimus-Eluting Bioresorbable Scaffolds against angiographic assessment: the clinical outcomes

Researchers

Presenter

  • Stephen Hamshere

Principal Investigators

  • Alex Byrne

  • Roshan Weerackody

  • Andrew Wragg

  • Charles Knight

  • Anthony Mathur

  • Daniel Jones

Medical Centers

  • Barts and The London NHS Trust, London, United Kingdom

  • London Bridge Hospital, London, United Kingdom

  • Unknown, London, United Kingdom

  • London chest, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Everolimus

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved